Wait, we have a special offer for you! ✋

Get your exclusive discount now

YES, get the discount! No, I'd pay the full price
Global Radiopharmaceutical Theranostics Market Report 2024

Radiopharmaceutical Theranostics Global Market Report 2025 – By Product Type (Alpha Emitters, Beta Emitters, Positron Emission Tomography (PET) Tracers), By Source (Nuclear Reactors, Cyclotrons), By Radioisotope (Technetium-99, Gallium-68, Iodine-131, Iodine-123, 18F, Y-90, Lutetium (Lu) 177, Copper (Cu) 67, Copper (Cu) 64, Other Radioscopes), By Indication (Oncology, Cardiology, Neurology, Other Indications), By End User (Hospitals, Diagnostic Imaging Centers, Academic And Research Institutes, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

Radiopharmaceutical Theranostics Global Market Report 2025

Report Price : $4490.00 | Pages : | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request a Sample
Request For Discount
Customise Your Report
Item added to cart!
Request For Proposal
Request For Regional Data
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying
Radiopharmaceutical Theranostics Global Market Report 2025

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Radiopharmaceutical Theranostics Market Definition

Radiopharmaceutical theranostics refers to a combined approach in medicine that combines therapeutics (treatment) and diagnostics (diagnosis) using radiopharmaceuticals. These are used for patient diagnosis, therapy, and personalized management.

The main product types of radiopharmaceutical theranostics are alpha emitters, beta emitters, and positron emission tomography (pet) tracers. Alpha emitters refer to radioactive substances that emit alpha particles, which are high-energy particles consisting of two protons and two neutrons. The various sources include nuclear reactors, cyclotrons, and the various radioisotopes include technetium-99, gallium-68, iodine-131, iodine-123, 18F, Y-90, lutetium (Lu) 177, copper (Cu) 67, copper (Cu) 64, and others. These various indications include oncology, cardiology, neurology, and other indications and are used by various end-users such as hospitals, diagnostic imaging centers, academic and research institutes, and others.

Radiopharmaceutical Theranostics Market Segmentation

The radiopharmaceutical theranostics market covered in this report is segmented –

1) By Product Type: Alpha Emitters, Beta Emitters, Positron Emission Tomography (PET) Tracers

2) By Source: Nuclear Reactors, Cyclotrons

3) By Radioisotope: Technetium-99, Gallium-68, Iodine-131, Iodine-123, 18F, Y-90, Lutetium (Lu) 177, Copper (Cu) 67, Copper (Cu) 64, Other Radioscopes

4) By Indication: Oncology, Cardiology, Neurology, Other Indications

5) By End User: Hospitals, Diagnostic Imaging Centers, Academic And Research Institutes, Other End Users

Subsegments:

1) By Alpha Emitters: Actinium-225, Radium-223, Bismuth-213, Other Alpha-Emitting Radiopharmaceuticals

2) By Beta Emitters: Iodine-131, Lutetium-177, Yttrium-90, Other Beta-Emitting Radiopharmaceuticals

3) By Positron Emission Tomography (PET) Tracers: Fluorodeoxyglucose (FDG), Gallium-68, Carbon-11, Other PET Tracers

Radiopharmaceutical Theranostics Market Size and growth rate 2025 to 2029: Graph

Radiopharmaceutical Theranostics Market Size 2025 And Growth Rate

The radiopharmaceutical theranostics market size has grown rapidly in recent years. It will grow from $2.88 billion in 2024 to $3.27 billion in 2025 at a compound annual growth rate (CAGR) of 13.7%. The growth in the historic period can be attributed to radiopharmaceutical development, clinical research advances, investment in research, regulatory approval, and nuclear medicine progress

Radiopharmaceutical Theranostics Market Growth Forecast

The radiopharmaceutical theranostics market size is expected to see rapid growth in the next few years. It will grow to $5.76 billion in 2029 at a compound annual growth rate (CAGR) of 15.2%. The growth in the forecast period can be attributed to biomarker discovery and validation, genomic and proteomic technologies, precision radiotherapy development, interdisciplinary collaborations, patient advocacy and support. Major trends in the forecast period include ethical and legal considerations, telemedicine in theranostics, patient-centric care, radiopharmaceutical customization, and nano-theranostics development.

Book your 30 minutes free consultation with our research experts

Contact Us

Radiopharmaceutical Theranostics Market Driver: The Surge In Cancer Incidence Boosts Radiopharmaceutical Theranostics Market Growth

The rising incidence of cancer is expected to propel the growth of the radiopharmaceutical theranostics market going forward. Cancer refers to a disease or condition of complex and abnormal growth of cells that can invade and spread to other parts of the body. Radiopharmaceutical theranostics helps in cancer treatment by providing targeted and personalized approaches. For instance, in 2023, according to the American Cancer Society, a US-based voluntary cancer health organization, in the US, 1.9 million new cancer cases are estimated to be diagnosed and about 609,820 deaths may occur due to cancer. Further, 88% of the people diagnosed are expected to belong to the 50 years or above age group. Therefore, the rising incidence of cancer is driving the growth of the radiopharmaceutical theranostics market.

Radiopharmaceutical Theranostics Market Driver: Rising Healthcare Expenditure Fuels Growth In Radiopharmaceutical Theranostics Market

Growing healthcare expenditure is significantly contributing to the growth of the radiopharmaceutical theranostics market going forward. Supportive government initiatives, grants, and funding for research and development in the field of radiopharmaceutical theranostics encourage innovation and the commercialization of new products. For instance, in October 2024, according to the Centers for Medicare & Medicaid Services, a US-based federal agency, prescription drug spending rose by 8.4% to reach $405.9 billion in 2022, outpacing the 6.8% growth recorded in 2021. Therefore, the growing healthcare expenditure will drive the radiopharmaceutical theranostics market.

Global Radiopharmaceutical Theranostics Market Major Players

Major companies operating in the radiopharmaceutical theranostics market include Cardinal Health Inc., GE HealthCare Technologies Inc., Bayer AG, China Grand Pharmaceutical & Healthcare., Lantheus Medical Imaging Inc., Curium Pharma, Advanced Accelerator Applications, Telix Pharmaceuticals Ltd., Bracco Imaging S.p.A, NTP Radioisotopes SOC Ltd., Navidea Biopharmaceuticals Inc., Jubilant DraxImage Inc., NorthStar Medical Radioisotopes LLC, Blue Earth Diagnostics Ltd., Precirix NV, SpectronRx, Viewpoint Molecular Targeting Inc., NuView Life Sciences, Alpha-9 Theranostics Inc., RadioMedix Inc, RayzeBio Inc, Fusion Pharmaceuticals Inc, Actinium Pharmaceuticals Inc., Eckert & Ziegler Strahlen- und Medizintechnik AG, Ariceum Therapeutics GmbH, Radiopharm Theranostics Ltd, Ratio Therapeutics Inc, Primo Biotechnology, Bivision Biomedical Technology (Nanjing) Co. Ltd.

Global Radiopharmaceutical Theranostics Market Trend: Technological Advancements Propel Radiopharmaceutical Theranostics Market Growth

Major companies operating in the radiopharmaceutical theranostics market are adopting a strategic partnership approach to develop innovative therapies. Strategic partnerships help radiopharmaceutical theranostics companies by combining resources and expertise, enhancing research and development capabilities, expanding market reach, and accelerating commercialization, ultimately driving innovation and growth in the radiopharmaceutical theranostics industry. For instance, in March 2023, Radiopharm Theranostics, an Australia-based biotechnology company, partnered with Pharma15 Corporation, a US-based venture, to develop next-generation therapeutic radiopharmaceuticals targeting prostate cancer, specifically focusing on overcoming resistance to existing PSMA-targeted therapies while enhancing selectivity to minimize toxicity in healthy tissues.

Global Radiopharmaceutical Theranostics Market Trend: Advancements In Theranostics For Targeted Cancer Treatment By Major Companies In Radiopharmaceutical Market

Major companies operating in the radiopharmaceutical theranostics market are focusing on developing theranostics aimed at curing cancer. Theranostic approaches are being explored for the treatment of rare diseases, with efforts to provide targeted therapies and diagnostic solutions for patients with limited treatment options such as cancer. For instance, in November 2023, GE HealthCare Technologies Inc., a US-based medical technology company, launched theranostics solutions for cancer. Theranostics is a new field of precision medicine that uses therapeutic agents in combination with imaging technology to identify and target cancer cells for destruction.

Radiopharmaceutical Theranostics Market Merger And Acquisition: Innovative Acquisition By Radiopharm Theranostics To Advance Next-Generation Radiopharmaceuticals For Prostate Cancer Treatment

In March 2023, Radiopharm Theranostics, an Australia-based biotechnology company specializing in radiopharmaceutical products, acquired Pharma15 Corporation for $4 million. Through this acquisition, Radiopharm aims to explore the potential of next-generation radiopharmaceuticals for the treatment of prostate cancer, with a focus on surpassing PSMA-based therapies and advancing innovative solutions for patients. Pharma15 Corporation is a US-based pharmaceutical company that specializes in the development of radio-immuno-theranostics platforms and pharmaceutical products.

Regional Outlook For The Global Radiopharmaceutical Theranostics Market

North America was the largest region in the radiopharmaceutical theranostics market in 2024. The regions covered in the radiopharmaceutical theranostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the radiopharmaceutical theranostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Radiopharmaceutical Theranostics Market?

The radiopharmaceutical theranostics market includes revenues earned by providing genetic testing, targeted therapy services, contract development, and manufacturing services, consultation and interpretation, and personalized therapeutic interventions. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Radiopharmaceutical Theranostics Industry?

The radiopharmaceutical theranostics market research report is one of a series of new reports from The Business Research Company that provides radiopharmaceutical theranostics market statistics, including radiopharmaceutical theranostics industry global market size, regional shares, competitors with a radiopharmaceutical theranostics market share, detailed radiopharmaceutical theranostics market segments, market trends, and opportunities, and any further data you may need to thrive in the radiopharmaceutical theranostics industry. This radiopharmaceutical theranostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Radiopharmaceutical Theranostics Market Report Forecast Analysis
Report AttributeDetails
Market Size Value In 2025 $3.27 billion
Revenue Forecast In 2034 $5.76 billion
Growth Rate CAGR of 15.2% from 2024 to 2033
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Product Type: Alpha Emitters, Beta Emitters, Positron Emission Tomography (PET) Tracers
2) By Source: Nuclear Reactors, Cyclotrons
3) By Radioisotope: Technetium-99, Gallium-68, Iodine-131, Iodine-123, 18F, Y-90, Lutetium (Lu) 177, Copper (Cu) 67, Copper (Cu) 64, Other Radioscopes
4) By Indication: Oncology, Cardiology, Neurology, Other Indications
5) By End User: Hospitals, Diagnostic Imaging Centers, Academic And Research Institutes, Other End Users Subsegments: 1) By Alpha Emitters: Actinium-225, Radium-223, Bismuth-213, Other Alpha-Emitting Radiopharmaceuticals
2) By Beta Emitters: Iodine-131, Lutetium-177, Yttrium-90, Other Beta-Emitting Radiopharmaceuticals
3) By Positron Emission Tomography (PET) Tracers: Fluorodeoxyglucose (FDG), Gallium-68, Carbon-11, Other PET Tracers
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Cardinal Health Inc., GE HealthCare Technologies Inc., Bayer AG, China Grand Pharmaceutical & Healthcare., Lantheus Medical Imaging Inc., Curium Pharma, Advanced Accelerator Applications, Telix Pharmaceuticals Ltd., Bracco Imaging S.p.A, NTP Radioisotopes SOC Ltd., Navidea Biopharmaceuticals Inc., Jubilant DraxImage Inc., NorthStar Medical Radioisotopes LLC, Blue Earth Diagnostics Ltd., Precirix NV, SpectronRx, Viewpoint Molecular Targeting Inc., NuView Life Sciences, Alpha-9 Theranostics Inc., RadioMedix Inc, RayzeBio Inc, Fusion Pharmaceuticals Inc, Actinium Pharmaceuticals Inc., Eckert & Ziegler Strahlen- und Medizintechnik AG, Ariceum Therapeutics GmbH, Radiopharm Theranostics Ltd, Ratio Therapeutics Inc, Primo Biotechnology, Bivision Biomedical Technology (Nanjing) Co. Ltd.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Radiopharmaceutical Theranostics Market Characteristics

    3. Radiopharmaceutical Theranostics Market Trends And Strategies

    4. Radiopharmaceutical Theranostics Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

    5. Global Radiopharmaceutical Theranostics Growth Analysis And Strategic Analysis Framework

    5.1. Global Radiopharmaceutical Theranostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

    5.2. Analysis Of End Use Industries

    5.3. Global Radiopharmaceutical Theranostics Market Growth Rate Analysis

    5.4. Global Radiopharmaceutical Theranostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

    5.5. Global Radiopharmaceutical Theranostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

    5.6. Global Radiopharmaceutical Theranostics Total Addressable Market (TAM)

    6. Radiopharmaceutical Theranostics Market Segmentation

    6.1. Global Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Alpha Emitters

    Beta Emitters

    Positron Emission Tomography (PET) Tracers

    6.2. Global Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Nuclear Reactors

    Cyclotrons

    6.3. Global Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Technetium-99

    Gallium-68

    Iodine-131

    Iodine-123

    18F

    Y-90

    Lutetium (Lu) 177

    Copper (Cu) 67

    Copper (Cu) 64

    Other Radioscopes

    6.4. Global Radiopharmaceutical Theranostics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Oncology

    Cardiology

    Neurology

    Other Indications

    6.5. Global Radiopharmaceutical Theranostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Hospitals

    Diagnostic Imaging Centers

    Academic And Research Institutes

    Other End Users

    6.6. Global Radiopharmaceutical Theranostics Market, Sub-Segmentation Of Alpha Emitters, By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Actinium-225

    Radium-223

    Bismuth-213

    Other Alpha-Emitting Radiopharmaceuticals

    6.7. Global Radiopharmaceutical Theranostics Market, Sub-Segmentation Of Beta Emitters, By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Iodine-131

    Lutetium-177

    Yttrium-90

    Other Beta-Emitting Radiopharmaceuticals

    6.8. Global Radiopharmaceutical Theranostics Market, Sub-Segmentation Of Positron Emission Tomography (PET) Tracers, By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Fluorodeoxyglucose (FDG)

    Gallium-68

    Carbon-11

    Other PET Tracers

    7. Radiopharmaceutical Theranostics Market Regional And Country Analysis

    7.1. Global Radiopharmaceutical Theranostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    7.2. Global Radiopharmaceutical Theranostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8. Asia-Pacific Radiopharmaceutical Theranostics Market

    8.1. Asia-Pacific Radiopharmaceutical Theranostics Market Overview

    Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.3. Asia-Pacific Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.4. Asia-Pacific Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    9. China Radiopharmaceutical Theranostics Market

    9.1. China Radiopharmaceutical Theranostics Market Overview

    9.2. China Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.3. China Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.4. China Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    10. India Radiopharmaceutical Theranostics Market

    10.1. India Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.2. India Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.3. India Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11. Japan Radiopharmaceutical Theranostics Market

    11.1. Japan Radiopharmaceutical Theranostics Market Overview

    11.2. Japan Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.3. Japan Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.4. Japan Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12. Australia Radiopharmaceutical Theranostics Market

    12.1. Australia Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.2. Australia Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.3. Australia Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13. Indonesia Radiopharmaceutical Theranostics Market

    13.1. Indonesia Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.2. Indonesia Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.3. Indonesia Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14. South Korea Radiopharmaceutical Theranostics Market

    14.1. South Korea Radiopharmaceutical Theranostics Market Overview

    14.2. South Korea Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.3. South Korea Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.4. South Korea Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15. Western Europe Radiopharmaceutical Theranostics Market

    15.1. Western Europe Radiopharmaceutical Theranostics Market Overview

    15.2. Western Europe Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.3. Western Europe Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.4. Western Europe Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16. UK Radiopharmaceutical Theranostics Market

    16.1. UK Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.2. UK Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.3. UK Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17. Germany Radiopharmaceutical Theranostics Market

    17.1. Germany Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.2. Germany Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.3. Germany Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18. France Radiopharmaceutical Theranostics Market

    18.1. France Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.2. France Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.3. France Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19. Italy Radiopharmaceutical Theranostics Market

    19.1. Italy Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.2. Italy Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.3. Italy Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20. Spain Radiopharmaceutical Theranostics Market

    20.1. Spain Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.2. Spain Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.3. Spain Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21. Eastern Europe Radiopharmaceutical Theranostics Market

    21.1. Eastern Europe Radiopharmaceutical Theranostics Market Overview

    21.2. Eastern Europe Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.3. Eastern Europe Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.4. Eastern Europe Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22. Russia Radiopharmaceutical Theranostics Market

    22.1. Russia Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.2. Russia Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.3. Russia Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23. North America Radiopharmaceutical Theranostics Market

    23.1. North America Radiopharmaceutical Theranostics Market Overview

    23.2. North America Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.3. North America Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.4. North America Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24. USA Radiopharmaceutical Theranostics Market

    24.1. USA Radiopharmaceutical Theranostics Market Overview

    24.2. USA Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.3. USA Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.4. USA Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25. Canada Radiopharmaceutical Theranostics Market

    25.1. Canada Radiopharmaceutical Theranostics Market Overview

    25.2. Canada Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.3. Canada Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.4. Canada Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26. South America Radiopharmaceutical Theranostics Market

    26.1. South America Radiopharmaceutical Theranostics Market Overview

    26.2. South America Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.3. South America Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.4. South America Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27. Brazil Radiopharmaceutical Theranostics Market

    27.1. Brazil Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.2. Brazil Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.3. Brazil Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28. Middle East Radiopharmaceutical Theranostics Market

    28.1. Middle East Radiopharmaceutical Theranostics Market Overview

    28.2. Middle East Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.3. Middle East Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.4. Middle East Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29. Africa Radiopharmaceutical Theranostics Market

    29.1. Africa Radiopharmaceutical Theranostics Market Overview

    29.2. Africa Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.3. Africa Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.4. Africa Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    30. Radiopharmaceutical Theranostics Market Competitive Landscape And Company Profiles

    30.1. Radiopharmaceutical Theranostics Market Competitive Landscape

    30.2. Radiopharmaceutical Theranostics Market Company Profiles

    30.2.1. Cardinal Health Inc. Overview, Products and Services, Strategy and Financial Analysis

    30.2.2. GE HealthCare Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

    30.2.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

    30.2.4. China Grand Pharmaceutical & Healthcare. Overview, Products and Services, Strategy and Financial Analysis

    30.2.5. Lantheus Medical Imaging Inc. Overview, Products and Services, Strategy and Financial Analysis

    31. Radiopharmaceutical Theranostics Market Other Major And Innovative Companies

    31.1. Curium Pharma

    31.2. Advanced Accelerator Applications

    31.3. Telix Pharmaceuticals Ltd.

    31.4. Bracco Imaging S.p.A

    31.5. NTP Radioisotopes SOC Ltd.

    31.6. Navidea Biopharmaceuticals Inc.

    31.7. Jubilant DraxImage Inc.

    31.8. NorthStar Medical Radioisotopes LLC

    31.9. Blue Earth Diagnostics Ltd.

    31.10. Precirix NV

    31.11. SpectronRx

    31.12. Viewpoint Molecular Targeting Inc.

    31.13. NuView Life Sciences

    31.14. Alpha-9 Theranostics Inc.

    31.15. RadioMedix Inc

    32. Global Radiopharmaceutical Theranostics Market Competitive Benchmarking And Dashboard

    33. Key Mergers And Acquisitions In The Radiopharmaceutical Theranostics Market

    34. Recent Developments In The Radiopharmaceutical Theranostics Market

    35. Radiopharmaceutical Theranostics Market High Potential Countries, Segments and Strategies

    35.1 Radiopharmaceutical Theranostics Market In 2029 - Countries Offering Most New Opportunities

    35.2 Radiopharmaceutical Theranostics Market In 2029 - Segments Offering Most New Opportunities

    35.3 Radiopharmaceutical Theranostics Market In 2029 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Radiopharmaceutical Theranostics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Radiopharmaceutical Theranostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Radiopharmaceutical Theranostics Market, Sub-Segmentation Of Alpha Emitters, By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Radiopharmaceutical Theranostics Market, Sub-Segmentation Of Beta Emitters, By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Radiopharmaceutical Theranostics Market, Sub-Segmentation Of Positron Emission Tomography (PET) Tracers, By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Radiopharmaceutical Theranostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Global Radiopharmaceutical Theranostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Asia-Pacific, Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: Asia-Pacific, Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: China, Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: China, Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: India, Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: India, Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Japan, Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Japan, Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Australia, Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Australia, Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Indonesia, Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: Indonesia, Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: South Korea, Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: South Korea, Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Western Europe, Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: Western Europe, Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: UK, Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: UK, Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Germany, Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: Germany, Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: France, Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: France, Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Italy, Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Italy, Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Spain, Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Spain, Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Eastern Europe, Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Eastern Europe, Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Russia, Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Russia, Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: North America, Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: North America, Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: USA, Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: USA, Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: Canada, Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: Canada, Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: South America, Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: South America, Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Brazil, Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Brazil, Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Middle East, Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Middle East, Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Africa, Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Africa, Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 79: Cardinal Health Inc. Financial Performance
  • Table 80: GE HealthCare Technologies Inc. Financial Performance
  • Table 81: Bayer AG Financial Performance
  • Table 82: China Grand Pharmaceutical & Healthcare. Financial Performance
  • Table 83: Lantheus Medical Imaging Inc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Radiopharmaceutical Theranostics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Radiopharmaceutical Theranostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Radiopharmaceutical Theranostics Market, Sub-Segmentation Of Alpha Emitters, By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Radiopharmaceutical Theranostics Market, Sub-Segmentation Of Beta Emitters, By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Radiopharmaceutical Theranostics Market, Sub-Segmentation Of Positron Emission Tomography (PET) Tracers, By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Radiopharmaceutical Theranostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Global Radiopharmaceutical Theranostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Asia-Pacific, Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: Asia-Pacific, Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: China, Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: China, Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: India, Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: India, Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Japan, Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Japan, Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Australia, Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Australia, Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Indonesia, Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: Indonesia, Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: South Korea, Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: South Korea, Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Western Europe, Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: Western Europe, Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: UK, Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: UK, Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Germany, Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: Germany, Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: France, Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: France, Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Italy, Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Italy, Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Spain, Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Spain, Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Eastern Europe, Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Eastern Europe, Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Russia, Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Russia, Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: North America, Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: North America, Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: USA, Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: USA, Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: Canada, Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: Canada, Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: South America, Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: South America, Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Brazil, Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Brazil, Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Middle East, Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Middle East, Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Africa, Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Africa, Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 79: Cardinal Health Inc. Financial Performance
  • Figure 80: GE HealthCare Technologies Inc. Financial Performance
  • Figure 81: Bayer AG Financial Performance
  • Figure 82: China Grand Pharmaceutical & Healthcare. Financial Performance
  • Figure 83: Lantheus Medical Imaging Inc. Financial Performance

Forecasting Till 2030: Opportunities And Strategies In The Global Value Based Care Payment Market – Includes Value Based Care Payment Market Analysis

Read More

How Will The Nuclear Medicine Market Grow In 2022?

Read More

What Is The Pediatric Imaging Market Overview In 2022?

Read More

Latest Healthcare Technology Management Market Growth Study 2022-2026 By The Business Research Company

Read More

The Business Research Company offers the clinical chemistry market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the hospital acquired infection control market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the multiplex assays market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the healthcare it consulting market research report 2022 with industry size, share, segments and market growth

Read More

Software Products Global Market Report 2025 – By Type (Operating Systems & Productivity Software Publishing, Database, Storage & Backup Software Publishing, Business Analytics & Enterprise Software, Video Game Software, Design, Editing & Rendering Software), By Application (Large Enterprises, Small And Medium Enterprises), By End-User Industry (BFSI, Media And Entertainment, IT and Telecommunications, Energy And Utilities, Government And Public Sector, Retail And Consumer Goods, Manufacturing, Other End User Industries) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Healthcare Cloud Computing Global Market Report 2025 – By Deployment Model (Private Cloud, Hybrid Cloud, Public Cloud), By End User (Healthcare Providers, Healthcare Payers), By Pricing Model (Pay-as-you-go, Spot Pricing), By Service Model (Software-as-a-Service (SaaS), Infrastructure-as-a-Service (IaaS), Platform-as-a-Service (PaaS)), By Application (Clinical Information System, Non-Clinical Information System) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Software as a service (SaaS) Global Market Report 2025 – By Application (Customer Relationship Management (CRM), Enterprise Resource Planning (ERP), Human Resource Management (HRM), Manufacturing and Operations, Supply Chain Management (SCM)), By Deployment Model (Public Cloud, Private Cloud, Hybrid Cloud), By Enterprise Size (Small & Medium Enterprises (SMEs), Large Enterprises), By End User (Manufacturing, Retail, Education, Healthcare, IT & Telecom, BFSI, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Healthcare Data Storage Global Market Report 2025 – By Type (Magnetic Storage, Flash Storage, Solid- State Storage), By Architecture (Block Storage, File Storage, Object Storage), By Deployment (On-Premise Solutions, Remote Solutions, Hybrid Solutions), By End User (Pharmaceutical, Hospitals, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Healthcare IT Integration Global Market Report 2025 – By Component (Product, Service), By Application (Clinic Integration, Radiology Integration, Lab Integration, Hospital Integration, Other Applications) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Healthcare EDI Global Market Report 2025 – By Component (Software, Hardware, Services), By Transaction (Claim Management, Healthcare Supply Chain, Other Transactions), By Mode of Delivery (Mobile, VAN, Web And Cloud-based, Point-to-point), By End User (Healthcare Provider, Payer, Pharmacies, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Software Consulting Global Market Report 2025 – By Type (Enterprise Solutions, Application Development, Migration and Maintenance Services, Design Services), By Enterprise Size (Large Enterprise, Small & Medium Enterprise), By End-Use Industry (Automotive, Education, Government, Healthcare, IT and Telecom, Manufacturing) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Software And BPO Services Global Market Report 2025 – By Type (BPO Services, Software Services), By Organization Size (Large Enterprises, Small And Medium Enterprises), By End-Use Industry (Financial Services, Retail & Wholesale, Information Technology, Manufacturing, Healthcare, Other End-User Industries) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the Radiopharmaceutical Theranostics market?

Radiopharmaceutical theranostics refers to a combined approach in medicine that combines therapeutics (treatment) and diagnostics (diagnosis) using radiopharmaceuticals. These are used for patient diagnosis, therapy, and personalized management. For further insights on the Radiopharmaceutical Theranostics market, request a sample here

How will the Radiopharmaceutical Theranostics market drivers and restraints affect the market dynamics? What forces will shape the Radiopharmaceutical Theranostics industry going forward?

The Radiopharmaceutical Theranostics market major growth driver - The Surge In Cancer Incidence Boosts Radiopharmaceutical Theranostics Market Growth. For further insights on the Radiopharmaceutical Theranostics market, request a sample here

What is the forecast market size or the forecast market value of the Radiopharmaceutical Theranostics market?

The Radiopharmaceutical Theranostics market size has grown strongly in recent years. The radiopharmaceutical theranostics market size has grown rapidly in recent years. It will grow from $2.88 billion in 2024 to $3.27 billion in 2025 at a compound annual growth rate (CAGR) of 13.7%. The growth in the historic period can be attributed to radiopharmaceutical development, clinical research advances, investment in research, regulatory approval, and nuclear medicine progress The radiopharmaceutical theranostics market size is expected to see rapid growth in the next few years. It will grow to $5.76 billion in 2029 at a compound annual growth rate (CAGR) of 15.2%. The growth in the forecast period can be attributed to biomarker discovery and validation, genomic and proteomic technologies, precision radiotherapy development, interdisciplinary collaborations, patient advocacy and support. Major trends in the forecast period include ethical and legal considerations, telemedicine in theranostics, patient-centric care, radiopharmaceutical customization, and nano-theranostics development. For further insights on the Radiopharmaceutical Theranostics market, request a sample here

How is the Radiopharmaceutical Theranostics market segmented?

The radiopharmaceutical theranostics market covered in this report is segmented –
1) By Product Type: Alpha Emitters, Beta Emitters, Positron Emission Tomography (PET) Tracers
2) By Source: Nuclear Reactors, Cyclotrons
3) By Radioisotope: Technetium-99, Gallium-68, Iodine-131, Iodine-123, 18F, Y-90, Lutetium (Lu) 177, Copper (Cu) 67, Copper (Cu) 64, Other Radioscopes
4) By Indication: Oncology, Cardiology, Neurology, Other Indications
5) By End User: Hospitals, Diagnostic Imaging Centers, Academic And Research Institutes, Other End Users Subsegments:
1) By Alpha Emitters: Actinium-225, Radium-223, Bismuth-213, Other Alpha-Emitting Radiopharmaceuticals
2) By Beta Emitters: Iodine-131, Lutetium-177, Yttrium-90, Other Beta-Emitting Radiopharmaceuticals
3) By Positron Emission Tomography (PET) Tracers: Fluorodeoxyglucose (FDG), Gallium-68, Carbon-11, Other PET Tracers For further insights on the Radiopharmaceutical Theranostics market, request a sample here

Which region has the largest share of the Radiopharmaceutical Theranostics market? What are the other regions covered in the report?

North America was the largest region in the radiopharmaceutical theranostics market in 2024. The regions covered in the radiopharmaceutical theranostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Radiopharmaceutical Theranostics market, request a sample here.

Who are the major players in the Radiopharmaceutical Theranostics market?

Major companies operating in the radiopharmaceutical theranostics market include Cardinal Health Inc., GE HealthCare Technologies Inc., Bayer AG, China Grand Pharmaceutical & Healthcare., Lantheus Medical Imaging Inc., Curium Pharma, Advanced Accelerator Applications, Telix Pharmaceuticals Ltd., Bracco Imaging S.p.A, NTP Radioisotopes SOC Ltd., Navidea Biopharmaceuticals Inc., Jubilant DraxImage Inc., NorthStar Medical Radioisotopes LLC, Blue Earth Diagnostics Ltd., Precirix NV, SpectronRx, Viewpoint Molecular Targeting Inc., NuView Life Sciences, Alpha-9 Theranostics Inc., RadioMedix Inc, RayzeBio Inc, Fusion Pharmaceuticals Inc, Actinium Pharmaceuticals Inc., Eckert & Ziegler Strahlen- und Medizintechnik AG, Ariceum Therapeutics GmbH, Radiopharm Theranostics Ltd, Ratio Therapeutics Inc, Primo Biotechnology, Bivision Biomedical Technology (Nanjing) Co. Ltd. . For further insights on the Radiopharmaceutical Theranostics market, request a sample here.

What are the key trends in the Radiopharmaceutical Theranostics market?

Major trends in the Radiopharmaceutical Theranostics market include Technological Advancements Propel Radiopharmaceutical Theranostics Market Growth. For further insights on the Radiopharmaceutical Theranostics market, request a sample here.

What are the major opportunities in the Radiopharmaceutical Theranostics market? What are the strategies for the Radiopharmaceutical Theranostics market?

For detailed insights on the major opportunities and strategies in the Radiopharmaceutical Theranostics market, request a sample here.

How does the Radiopharmaceutical Theranostics market relate to the overall economy and other similar markets?

For detailed insights on Radiopharmaceutical Theranostics's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Radiopharmaceutical Theranostics industry?

For detailed insights on the mergers and acquisitions in the Radiopharmaceutical Theranostics industry, request a sample here.

What are the key dynamics influencing the Radiopharmaceutical Theranostics market growth? SWOT analysis of the Radiopharmaceutical Theranostics market.

For detailed insights on the key dynamics influencing the Radiopharmaceutical Theranostics market growth and SWOT analysis of the Radiopharmaceutical Theranostics industry, request a sample here.